Bookmark
Forward
Pharmacology and Pharmacokinetics of Ubrogepant: A Potent, Selective Calcitonin Gene-Related Peptide Receptor Antagonist for the Acute Treatment of Migraine.
Andrew M Blumenfeld, Lars Edvinsson, Abhijeet Jakate, Pradeep Banerjee
The Journal of family practice 2020 Jan/Feb
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Andrew M Blumenfeld, Lars Edvinsson, Abhijeet Jakate, Pradeep Banerjee.
Pharmacology and Pharmacokinetics of Ubrogepant: A Potent, Selective Calcitonin Gene-Related Peptide Receptor Antagonist for the Acute Treatment of Migraine.
The Journal of family practice.
2020 Jan/Feb;69(1 Suppl):S8-S12
Mesh Tags
Acute Disease
Adolescent
Adult
Aged
Aged, 80 and over
Calcitonin Gene-Related Peptide Receptor Antagonists
Female
Humans
Male
Middle Aged
Migraine Disorders
Pyridines
Pyrroles
Risk Factors
Young Adult
Substances
Calcitonin Gene-Related Peptide Receptor Antagonists
Pyridines
Pyrroles
ubrogepant
PMID: 32053714
View Full Text